Shandra Eisenga Human Cell and Tissue Product Safety Act
The Shandra Eisenga Human Cell and Tissue Product Safety Act directs the Secretary of Health and Human Services to launch a public awareness campaign educating medical professionals about organ and tissue donation processes and available screening tests. The bill increases civil penalties for violating safety regulations regarding human cell and tissue products, raising fines to $20,000 per violation with a maximum limit of $10 million per legal proceeding. Additionally, it requires the Food and Drug Administration to publish data on inspections and response times, establish a public docket for comments on regulatory modernization, and submit a report to Congress by September 2026 with recommendations on improving oversight.
Bill status
in committee
1 of 4 stages cleared
Introduction
Jun 2026
Committee Review
Floor Vote
President
Introduced Jun 24, 2026
Last action Jun 24, 2026
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
2
Key actions
0
Committee
1
Jun 24, 2026
Committee
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
upper
Jun 24, 2026
Introduced
Introduced in Senate
upper
1 primary · 1 co-sponsor
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about S 4885
Scope: US
Hi! I can help you understand S 4885. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline